Journal of Tissue Viability
Volume 19, Issue 3 , Pages 116-122 , August 2010

Tolerability and safety of conventional therapy combination with DeMarco formula for infected ischemic diabetic foot

  • Héctor Álvarez Duarte

      Affiliations

    • National Institute for Angiology and Vascular Surgery, Research Department, 1551 Calzada del Cerro, Postal code 12000, Havana City, Cuba
    • ,
  • Martha M. Fors López

      Affiliations

    • National Center for the Coordination of Clinical Assays, Havana, Cuba
    • ,
  • José Hernández Carretero

      Affiliations

    • National Institute for Angiology and Vascular Surgery, Research Department, 1551 Calzada del Cerro, Postal code 12000, Havana City, Cuba
    • ,
  • Miriam Mahia Vilas

      Affiliations

    • National Institute for Angiology and Vascular Surgery, Research Department, 1551 Calzada del Cerro, Postal code 12000, Havana City, Cuba
    • ,
  • Milagros García Mesa

      Affiliations

    • National Institute for Angiology and Vascular Surgery, Research Department, 1551 Calzada del Cerro, Postal code 12000, Havana City, Cuba
    • Corresponding Author InformationCorresponding author. Tel.: +537 878 6102.

References 

  1. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006;117:35S–41S
  2. Ebskov LB. Relative mortality in lower extremity amputees with diabetes mellitus. Prosthet Orthot Int. 1996;20:147–152
  3. Boutoille D, Leautez S, Maulaz D, Krempf M, Raffi F. Ulcers of the diabetic foot: epidemiology and physiopathology. Presse Med. 2000;29:389–392
  4. Younes NA, Albsoul AM, Awad H. Diabetic heel ulcers: a major risk factor for lower extremity amputation. Ostomy Wound Manage. 2004;50:50–60
  5. Mortalidad prematura por angiopatía diabética periférica en Cuba en los años 1990. Rev Cub Salud Pública 2006. 1995–2000;32(2):http://cielo.sld.cu/scielo.php[cited May 22, 2008]
  6. Ostfeld A, Smith CM, Stotsky BA. The systemic use of procaine in the treatment of the elderly: a review. J Am Geriatr Soc. 1977;25:1–19
  7. Morris T, Appbly R. Retardation of wound healing by procaine. Br J Surg. 1980;z67:391–392
  8. Hattori M, Dohi S, Nozaki M, Niwa M, Shimonaka H. The inhibitory effects of local anesthetics on superoxide generation of neutrophils correlate with their partition coefficients. Anesth Analg. 1997;84:405–412
  9. Dolganiuc A, Radu D, Olinescu A, Vrăbiescu A. Procain and diethylaminoethanol influence on the release of free oxygen radicals by polymorphonuclear leukocytes, in rabbits and humans. Roum Arch Microbiol Immunol. 1998;57:23–32
  10. Vacquier VD, Brandriff B. DNA synthesis in unfertilized sea urchin eggs can be turned on and turned off by the addition and the removal of procaine hydrochloride. Development Biol. 1975;47:12–31
  11. Pigeolet E, Raes M, Houbion A, Remacle J. Effect of procaine on cultivated human WI-38 fibroblasts. Exp Gerontol. 1988;23:87–96
  12. Banerjee D, Redman CM. Effect of local anesthetics on plasma protein secretion by rat hepatocytes. Biochim Biophys Acta. 1977;500:49–60
  13. Kaemmerer K, Kietzmann M. Intermediary effectiveness of procaine and procaine metabolites following oral administration. ZFA. 1989;44:189–199
  14. Pelz K, Wiedmann-Al-Ahmad M, Bogdan C, Otten JE. Analysis of the antimicrobial activity of local anaesthetics used for dental analgesia. J Med Microbiol. 2008;57:88–94
  15. Fenoglio C, Boicelli CA, Ottone M, Addario C, Chiari P, Viale M. Protective effect of procaine hydrochloride on cisplatin-induced alterations in rat kidney. Anticancer Drugs. 2002;13:1043–1054
  16. Huang Y, Lau CW, Chan FL, Yao XQ. Contribution of nitric oxide and K+ channel activation to vasorelaxation of isolated rat aorta induced by procaine. Eur J Pharmacol. 1999;3672–3673:231–237
  17. Brem H, Sheehan P, Rosenberg HJ, Schneider JS, Boulton AJ. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg. 2006;117(7 Suppl.):193S–209Sdiscussion 210S–211S
  18. Edmonds ME. ABC of wound healing. Diabetic foot ulcers. BMJ. 2006;332:407–410
  19. Hayama M, Yamamoto K, Kohori F, Uesaka T, Ueno Y, Sugaya H, et al. Nanoscopic behavior of polyvinylpyrrolidone particles on polysulfone/polyvinylpyrrolidone film. Biomaterials. 2004;25:1019–1028
  20. Regoeczi E. Labelled polyvinylpyrrolidone as an in vivo indicator of reticuloendothelial activity. Br J Exp Pathol. 1976;57:431–432
  21. Alvarez H, Fors M, Hernández J, Mahia M, Garcia M. Clinical evaluation of De Marco formula as an adjunctive therapy for infected ischemic diabetic foot: a prospective randomized controlled trial. Can J Clin Pharmacol. 2008;16:e381–e391
  22. Mc Cook Martínez J, Montalvo Diago J, Ariosa Coloma MC, Fernández Hernández P. Hacia una clasificación etiopatogénica del llamado pié diabético. Angiologia. 1979;39:7–11
  23. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21:247–254
  24. Moffitt EA. Blood substitutes. Can Anaesth Soc J. 1975;22:12–19
  25. Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med. 2004;29:333–340
  26. Mc CooK J. Pie Diabético: Epidemiología. Rev Cubana Hig Epidemiol. 1979;17:58163–58173
  27. Lima Santana B. Reamputaciones de miembros inferiores en pacientes diabéticos. Rev Cub Cirugia. 1982;21:194–202
  28. Vejerano García P, Rivero Fernández F, Gónzalez Gónzalez F. Morbilidad y mortalidad por pie diabético en nuestro servicio. Rev Cubana Endocrinol. 1990;1:142–147

PII: S0965-206X(10)00035-5

doi: 10.1016/j.jtv.2010.03.002

Journal of Tissue Viability
Volume 19, Issue 3 , Pages 116-122 , August 2010

Article Tools